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Introduction: The toxicological relevance of the micronucleus 
(MN) assey is well defined: it is a multi -target genotoxic 
endpoint, assessing not only clastogenic and aneugenic events 
but also some epigenetic effects, which is simple to score, 
accurate, applicable in different cell types. Scoring of 
micronuclei can be performed relatively easily and on 
different cell types relevant for human biomonitoring: 
lymphocytes, fibroblasts and exfoliated epithelial cells. Aims 
of the study: To indicate the importance of the application of 
micronucleus test as standardized cytogenetic method as an 
important biomarker in detecting the impact of ionizing 
radiation on the entire genetic material in occupationally 
exposed health care workers. Matherial and methods: The 
study include health professionals who are directly and on 
daily basses exposed to ionizing radiation as physical agents 
and a control group that represents young and healthy 
population that is not exposed to any physical and chemical 
agents. Results. The major advantage of lymphocytes is that 
they are primary cells, easy to culture in suspension. The 
choice between whole blood and isolated lymphocytes 
depends upon the question addressed. The most important 
differences among the protocols are the hypotonic treatment 
(critical in particular for image analysis), fixation of the cells 
(dependent on laboratory preferences) and the final slide 
preparation. Conclusion: In recent years the in vitro 
micronucleus test has become an attractive tool for 
genotoxicity testing because of its simplicity of scoring and 
wide applicability in different cell types but the lymphocytes 
are the most reperesentative cells for this kind of research.  






















Introduction: The in vitro micronucleus assay is a 
genotoxicity test for the detection of micronuclei (MN) in  
the cytoplasm of interphase cells. Micronuclei may  
originate from acentric chromosome fragments (i.e . 
lacking a centromere), or whole chromosomes that are 
unable to migrate to the poles during the anaphase stage of 
cell division. The assay detects the activity of clastogenic 
and aneugenic chemicals (Kirsch-Volders, M. (1997), 
Parry, J.M. and Sors, A. (1993),   in cells that have 
undergone cell division during or after exposure to the test 
substance. The addition of cytoB prior to the targeted 
mitosis allows for the identification and selective analysis 
of micronucleus frequency in cells that have completed  
one mitosis because such cells are binucleate (Fenech, M. 
and Morley, A.A. (1985), Kirsch-Volders and all.(2000) . 
The toxicological relevance of the micronucleus (MN) 
assey is well defined: it is a multi-target genotoxic 
endpoint, assessing not only clastogenic and aneugenic 
events but also some epigenetic effects, which is simple to 
score, accurate, applicable in different cell types. In 
addition, it is predictive for cancer, amenable for 
automation and allows good extrapolation for potential 
limits of exposure or thresholds and it is easily measured 
in experimental both in vitro and in 
vivo systems. Furthermore, the importance of adequate 
design of protocols is highlighted and new developments.  
We address future research perspectives including the 
possibility of a combined primary 3D human skin and 
primary human whole blood culture system, and the need 
for adaptation of the in vitro MN assays to assess the 
genotoxic potential of new materials, in particular 
nanomaterials. So many studies indicate that the use of cell 
lines can be recommended, it should be underlined that 
most of the cell lines are deficient in p53 or apoptosis  
controlling genes that lead to higher frequencies of MN  
and is thought to lead to positive results that are not 
confirmed in vivo in some cases. In contrast, for 
mechanistic studies, the use of cell lines can be very useful. 
The OECD guideline is not restricted to synchronised cells 
since it aims at maximising the probability of detecting an 
aneugen or clastogen acting at any stage of the cell cycle; 
therefore, a sufficient number of cells should be treated 
with the test substance during all the phases of their cell 
cycle (Volders and all., 2011). Scoring of micronuclei can 
be performed relatively easily and on different cell types 
relevant for human biomonitoring: lymphocytes, 
fibroblasts and exfoliated epithelial cells, without extra in  
vitro cultivation step. MN observed in exfoliated cells are 
not induced when the cells are at the epithelial surface, but 
when they are in the basal layer. An ex vivo/ in vitro  
analysis of lymphocytes in the presence of cytochalasin-B 
(added 44 hours after the start of cultivation), an inhibitor 
of actins, allows to distinguish easily between 
mononucleated cells which did not divide and binucleated 
cells which completed nuclear division during in vitro  
culture. Indeed, in these conditions the frequencies of 
mononucleated cells provide an indication of the 
background level of chromosome/genome mutations 
accumulated in vivo and the frequencies of binucleated 
cells with MN a measure of the damage accumulated  
before cultivation plus mutations expressed during the 
first in vitro mitosis. In the absence of cytochalasin B, 
mononucleated cells are analyzed for the presence of 
micronuclei. In the presence of cytochalasin B, 
mononucleated cells are recommended to be harvested at 
24 hours post-PHA stimulation as there can be no doubt at 
this time-point that MN within such a cell are a result of in  
vivo rather than ex vivo division. Binucleated cells are 
recommended to be harvested at 72 hours post-PHA. 
Moreover, 24 hour post-PHA time-point may be the right  
time to count apoptotic/necrotic cells (Kirsch-Volders et 
all., 2001). During or after exposure to the test substance, 
the cells are grown for a period sufficient to allow 
chromosome or spindle damage to lead to the formation of 
micronuclei in interphase cells. For induction of 
aneuploidy, the test substance should ordinarily be present 
during mitosis. Harvested and stained interphase cells are 
analysed for the presence of micronuclei. Ideally , 
micronuclei should only be scored in those cells that have 
completed mitosis during exposure to the test substance or 
during the post exposure period, if one is used. In cultures 
that have been treated with a cytokinesis blocker, this is 
achieved by scoring only binucleated cells. In the absence 
of a cytokinesis blocker, it is important to demonstrate that 
the cells analysed are likely to have undergone cell 
division during or after exposure to the test substance. For 
all protocols, it is important to demonstrate that cell 
proliferation has occurred in both the control and treated 
cultures, and the extent of test substance-induced 
cytotoxicity or cytostasis should be assessed in the cultures 
(or in parallel cultures) that are scored for micronuclei. The 
effects in early responding tissues are a very important  
issue in radiotherapy  (Elyan, S.A. et all.1998). Normal 
tissue intrinsic radiosensitivity is the main limiting factor 
for total irradiation dose in clinical practice defining a 
normal tissue tolerance to irradiation  (RefBurnet,et all. 
(1994), Peacock, J., Ashton, A., Bliss, J. et all. (2000);  
West, C.M., Davidson; S.E., Elyan, S.A. et all. (2001).  
Pelvic organs morbidity after irradiation of cancer patients 
remains a major problem, although new technologies have 
been developed and implemented. Multiple studies have 
shown that normal tissue morbidity after irradiation in  
cancer patients correlates with radiosensitivity of skin  
fibroblasts and peripheral blood lymphocytes of these 
patients. This finding stimulates the search of prognostic 
criteria for evaluating the intrinsic individual cellular 
radiosensitivity  (Elyan, S.A. et all. (1998); Biete, A.,et all. 
(2010). 
Aims of the study: To indicate the importance of the 
application of micronucleus test as standardized 
cytogenetic method as an important biomarker in detecting 
the impact of ionizing radiation on the entire genetic 
material in occupationally exposed health care workers . 
The micronucleus test (MNT) determines the frequency of 
the radiation induced micronuclei (MN) in peripheral 
blood lymphocytes, which could serve as an indicator of 
intrinsic cell radiosensitivity. After mutagen attack, MN in  
interphase cells are formed by mitotic loss of acentric 
fragments or chromosomes which are not incorporated in  
the daughter cell nuclei (Fenech, M. and Neville, S. (1992).  
Matherial and methods: The study include health 
professionals who are directly and on daily basses exposed 
to ionizing radiation as physical agents and a control group 
that represents young and healthy population that is not 
exposed to any physical and chemical agents. By applying 
the micronucleus test, quantitative and qualitative analysis 
are performed on binuclear lymphocytes and micronucleus  
as reliable indicators of possible chromosomal damage in  
the cells. For the scoring of micronuclei the following  
criteria were adopted from Fenech et all, (2003): the 
diameter of the MN should be less than one-third of the 
main nucleus, MN should be separated from or marginally  
overlap with main nucleus as long as there is clear 
identification of the nuclear boundary, MN should have 
similar staining as the main nucleus. Whole blood treated 
with an anti-coagulant (e.g. heparin), or separated 
lymphocytes, are cultured at 37°C in the presence of a 
mitogen e.g. phytohaemagglutinin (PHA) prior to 
exposure to the test substance and cytoB. 
Results . The number of micronucleus in the control group 
is in the normal reference values. The major advantage of 
lymphocytes is that they are primary cells, easy to culture 
in suspension. The choice between whole blood and 
isolated lymphocytes depends upon the question 
addressed. The most important differences among the 
protocols are the hypotonic treatment (critical in particular 
for image analysis), fixation of the cells (dependent on 
laboratory preferences) and the final slide preparation. 
These different parameters significantly influence cell 
density and cytoplasm preservation. A detailed protocol 
for isolated lymphocyte and whole blood culture MN 
assays was recently published and included detailed 
scoring criteria validated and recommended by protocol. 
Conclusion: In recent years the in vitro micronucleus test 
has become an attractive tool for genotoxicity testing 
because of its simplicity of scoring and wide applicability  
in different cell types. Because of its reliability and easy 
performance, MN asseys could be a promising method for 
evaluating normal tissue morbidity in cancer patients 
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